Symbol="CERE"
AssetType="Common Stock"
Name="Cerevel Therapeutics Holdings Inc"
Description="Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various therapies for neuroscientific diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1805387"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="131 DARTMOUTH STREET, SUITE 502, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="4149801000"
EBITDA="-389763008"
PERatio="None"
PEGRatio="None"
BookValue="2.754"
DividendPerShare="0"
DividendYield="0"
EPS="-2.64"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.319"
ReturnOnEquityTTM="-0.813"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.64"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="37.13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="6.96"
EVToRevenue="-"
EVToEBITDA="-11.68"
Beta="1.387"
num_52WeekHigh="41.46"
num_52WeekLow="22.63"
num_50DayMovingAverage="31.92"
num_200DayMovingAverage="29.55"
SharesOutstanding="156833000"
DividendDate="None"
ExDividendDate="None"
symbol="CERE"
open="25.75"
high="26.11"
low="23.68"
price="23.76"
volume="2370845.00"
latest_trading_day="2023-08-03"
previous_close="26.33"
change="-2.57"
change_percent="-9.7607%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="586549"
Change_recent_avg="0.01"
Delta_recent_avg="1.26"
Variance_recent_avg="0.63"
Change_ratio_recent_avg="-0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="1118"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0151.jpeg"
image_negative_thumbnail_id_2="1093"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0126.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="562"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_positive_thumbnail_id_1="615"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_positive_thumbnail_id_2="982"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0144.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
